Not a healthcare professional? Visit our Public site

report_adverse_events REPORT ADVERSE EVENT Login Register notification bell

Placeholder

    Contact us REQUEST A REPRESENTATIVE

    Your browser is not supported.

    To view this content, please use one of the following browsers:

    • Microsoft Edge
    • Chrome
    • Safari
    Rezzayo Logo

    Click here to access GB prescribing information or NI prescribing Information

    RESOURCES

    Expert presentations and opinions on REZZAYO® rezafungin

     

    Watch or listen to expert presentations and opinions on REZZAYO®, and access dedicated learning resources or materials for your patients

    Interested in learning more about how REZZAYO® could help in your hospital?
    Request an appointment with a Napp representative

    Request an appointment
    placeholder

    Mechanism of action (MOA)

    Discover the benefits of REZZAYO® mechanism of action

    VIDEO

     

    REZZAYO® rezafungin budget impact summary

    REZZAYO® rezafungin budget impact summary

    Calculate any potential cost saving that could be achieved by switching your patients from their current treatment.

    CALCULATOR

      Reporting adverse events

      Adverse events should be reported. Reporting forms and information can be found at http://yellowcard.mhra.gov.uk/.

      Adverse events should also be reported to Napp Pharmaceuticals Limited on 01223 424444 or drugsafetyUKandROI@mundipharma.com.

      ®: REZZAYO is a Registered Trademark of Cidara Therapeutics, Inc., used under license